Market Place
Sourcing Support
Median Tech Partners With Top Pharma For AI Imaging Biomarker Discovery
06 Aug 2024 //
BUSINESSWIRE
Oncology Pharma Releases Further Feasibility Studies, Data and Capacities
23 Feb 2022 //
BIOSPACE
Oncology Pharma Expands on Feasibility Studies and Data
17 Feb 2022 //
ACCESSWIRE
Oncology Pharma, Regen Bio to Jointly Develop Modified mRNA anti-Cancer Vaccine
14 Feb 2022 //
ACCESSWIRE
Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress
27 Oct 2021 //
ACCESSWIRE
Oncology Pharma Engages PCAOB Audit Firm, Moves Company Towards Senior Listing
15 Oct 2021 //
BIOSPACE
Oncology Pharma Update on PCAOB Audit Selection Process and License Agreement
12 Oct 2021 //
BIOSPACE
Oncology Pharma Has Received the Committed Funding to Perform IND-Enabling Work
13 Sep 2021 //
BIOSPACE
Oncology Pharma`s Co-Development Agreement Pursues Strategic & Direct Objectives
23 Aug 2021 //
BIOSPACE
Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharma
19 Aug 2021 //
BIOSPACE
Oncology Analytics Releases FDA`s Q1 2021 Drug and Indications Approvals
10 Jun 2021 //
PRNEWSWIRE
Oncology, immunology to extend lead as top therapy areas
08 May 2021 //
FIERCE PHARMA
Oncology Pharma Has Provided Initial Funding to NanoSmart
31 Mar 2021 //
GLOBENEWSWIRE
Oncology Pharma Has Provided Initial Funding to NanoSmart Pharma
31 Mar 2021 //
BIOSPACE
Oncology Pharma Reveals Strategic Plans for Company Growth and Focus
15 Mar 2021 //
GLOBENEWSWIRE
Oncology Pharma Continues Licensing Agreement with NanoSmart
11 Mar 2020 //
GLOBE NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.